Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature

Amino Acids

Volumn 49, Issue 1, 2017, Pages 57-65

  Zheng, Hui Fei ^a,b   Wang, Wen Qiang ^a   Li, Xin Min ^b   Rauw, Gail ^b   Baker, Glen B ^b  

^a Xianyue Hospital   (China)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Amino acids; Autism spectrum disorders; d Serine; GABA; Glutamate; Glutamine; Glycine; Taurine; Tryptophan

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; AMINO ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; CITRULLINE; DEXTRO SERINE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; HOMOCYSTEINE; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; OXYTOCIN; PHENYLALANINE; PROLINE; TAURINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE; SERINE;

AMINO ACID BLOOD LEVEL; AMINO ACID BRAIN LEVEL; AMINO ACID METABOLISM; AMINO ACID URINE LEVEL; AUTISM; CEREBROSPINAL FLUID LEVEL; DRUG EFFECT; GABAERGIC SYSTEM; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; THROMBOCYTE; BODY FLUID; CHEMISTRY; METABOLISM; PATHOPHYSIOLOGY;

AMINO ACIDS; AUTISM SPECTRUM DISORDER; BODY FLUIDS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HUMANS; SERINE; TAURINE; TRYPTOPHAN;

EID: 84989201302     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-016-2332-y     Document Type: Review

References (124)

1. Abdulla AM, Hegde AM (2015) Salivary cortisol levels and its implication on behavior in children with autism during dental treatment. J Clin Pediatr Dent 39:128–132
2. Aldred S, Moore KM, Fitzgerald M, Waring RH (2003) Plasma amino acid levels in children with autism and their families. J Autism Dev Disord 33:93–97
3. Ali A, Waly MI, Al-Farsi YM et al (2011) Hyperhomocysteinemia among Omani autistic children: a case-control study. Acta Biochim Pol 58:547–551
4. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric, Washington, DC
5. Aoki Y, Kasai K, Yamasue H (2012) Age-related change in brain metabolite abnormalities in autism: a meta-analysis of proton magnetic resonance spectroscopy studies. Transl Psychiatry 2(e69):1–12
6. Arnold GL, Hyman SL, Mooney RA, Kirby RS (2003) Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J Autism Dev Disord 33:449–454
7. Bala KA, Dogan M, Mutluer T et al (2016) Plasma amino acid profile in autism spectrum disorder (ASD). Eur Rev Med Pharcol Sci 20:923–929
8. Balu DT, Coyle JT (2015) The NMDA receptor “glycine modulatory site” in schizophrenia: d-serine, glycine, and beyond. Curr Opin Pharmacol 20:109–115
9. Baptista V, Varanda WA (2005) Glycine binding site of the synaptic NMDA receptor in subpostremal NTS neurons. J Neurophysiol 94:147–152
10. Baron-Cohen S, Scott FJ, Allison C et al (2009) Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry 194:500–509
11. Basu AC, Tsai GE, Ma C-L et al (2009) Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry 14:719–727
12. Billard J-M (2015) d-Serine in the aging hippocampus. J Pharm Biomed Anal 116:18–24
13. Blatt GJ, Fatemi SH (2011) Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications. Anat Rec (Hoboken) 294:1646–1652
14. Blaylock RL (2008) A possible central mechanism in autism spectrum disorders, part 1. Altern Ther Health Med 14:46–53
15. Blaylock RL, Strunecka A (2009) Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. Curr Med Chem 16:157–170
16. Blumberg SJ, Bramlett MD, Kogan MD et al (2013) Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011–2012. Natl Health Stat Rep 65:1–11
17. Brian J, Bryson SE, Smith IM et al (2016) Stability and change in autism spectrum disorder diagnosis from age 3 to middle childhood in a high-risk sibling cohort. Autism 20:888–892
18. Cai J, Ding L, Zhang J-S et al (2016) Elevated plasma levels of glutamate in children with autism spectrum disorders. NeuroReport 27:272–276
19. Cochran DM, Sikoglu EM, Hodge SM et al (2015) Relationship among glutamine, γ-aminobutyric acid, and social cognition in autism spectrum disorders. J Child Adolesc Psychopharmacol 25:314–322
20. Cohen BI (2002) The significance of ammonia/gamma-aminobutyric acid (GABA) ratio for normality and liver disorders. Med Hypotheses 59:757–758
21. Coyle JT (2006) Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26:365–384
22. D’Ascenzo M, Podda MV, Grassi C (2014) The role of d-serine as co-agonist of NMDA receptors in the nucleus accumbens: relevance to cocaine addiction. Front Synaptic Neurosci 6:16
23. Desai A, Sequeira JM, Quadros EV (2016) The metabolic basis for developmental disorders due to defective folate transport. Biochimie 126:31–42
24. Deutschenbaur L, Beck J, Kiyhankhadiv A et al (2016) Role of calcium, glutamate and NMDA in major depression and therapeutic application. Prog Neuropsychopharmacol Biol Psychiatry 64:325–333
25. Dhossche D, Applegate H, Abraham A et al (2002) Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism. Med Sci Monit 8:1–6
26. Durrant AR, Heresco-Levy U (2014) d-Serine in neuropsychiatric disorders: new advances. Adv Psychiatry 2014:1–16
27. Edmiston EK, Merkle K, Corbett BA (2015) Neural and cortisol responses during play with human and computer partners in children with autism. Soc Cogn Affect Neurosci 10:1074–1083
28. El-Ansary A (2016) Data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients. Data Brief 7:111–116
29. El-Ansary A, Al-Ayadhi L (2014) GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders. J Neuroinflammation 11:189
30. Erickson CA, Wink LK, Early MC et al (2013) Brief report: pilot single-blind placebo lead-in study of acamprosate in youth with autistic disorder. J Autism Dev Disord 44:981–987
31. Evans C, Dunstan HR, Rothkirch T et al (2008) Altered amino acid excretion in children with autism. Nutr Neurosci 11:9–17
32. Fatemi SH (2008) The hyperglutamatergic hypothesis of autism. Prog Neuropsychopharmacol Biol Psychiatry 32:911
33. Fatemi SH, Halt AR, Stary JM et al (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 52:805–810
34. Feng L, Li C, Chiu H et al (2013) Autism spectrum disorder in Chinese populations: a brief review. Asia Pac Psychiatry 5:54–60
35. Fernstrom JD (2005) Branched-chain amino acids and brain function. J Nutr 135:1539–1546
36. Fuchs SA, Berger R, Klomp LWJ, de Koning TJ (2005) d-Amino acids in the central nervous system in health and disease. Mol Genet Metab 85:168–180
37. Fuchs SA, Berger R, de Koning TJ (2011) d-Serine: the right or wrong isoform? Brain Res 1401:104–117
38. Gaetz W, Bloy L, Wang DJ et al (2014) GABA estimation in the brains of children on the autism spectrum: measurement precision and regional cortical variation. Neuroimage 86:1–9
39. Geier DA, Kern JK, Garver CR et al (2009) A prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res 34:386–393
40. Ghanizadeh A (2010) Methionine sulfoximine may improve inflammation in autism, a novel hypothesized treatment for autism. Arch Med Res 41:651–652
41. Ghanizadeh A (2011) Could fever and neuroinflammation play a role in the neurobiology of autism? A subject worthy of more research. Int J Hyperthermia 27:737–738
42. Ghanizadeh A, Namazi MR (2010) A possible research and clinical implication of association of homocysteine and glutamate levels in brain for management of aggression. Int J Dev Neurosci 28:125
43. Ghanizadeh A, Akhondzadeh S, Hormozi M et al (2012) Glutathione-related factors and oxidative stress in autism, a review. Curr Med Chem 19:4000–4005
44. Gogolla N, Leblanc JJ, Quast KB et al (2009) Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord 1:172–181
45. Good P (2011a) Do salt cravings in children with autistic disorders reveal low blood sodium depleting brain taurine and glutamine? Med Hypotheses 77:1015–1021
46. Good P (2011b) Does fever relieve autistic behavior by improving brain blood flow? Neuropsychol Rev 21:66–67
47. Grant SL, Shulman Y, Tibbo P et al (2006) Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogr B 844:278–282
48. Hashimoto K, Yoshida T, Ishikawa M et al (2015) Increased serum levels of serine enantiomers in patients with depression. Acta Neuropsychiatr 28:173–178
49. Hashimoto K, Bruno D, Nierenberg J et al (2016) Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study. Transl Psychiatry 6:744–749
50. Hassan TH, Abdelrahman HM, Abdel Fattah NR et al (2013) Blood and brain glutamate levels in children with autistic disorder. Res Autism Spectr Disord 7:541–548
51. Howlin P, Asgharian A (1999) The diagnosis of autism and Asperger syndrome: findings from a survey of 770 families. Dev Med Child Neurol 41:834–839
52. Ito S (2016) GABA and glycine in the developing brain. J Physiol Sci 66:375–379
53. James SJ, Cutler P, Melnyk S et al (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:1611–1617
54. Joshi G, Biederman J, Wozniak J et al (2012) Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4T. Eur Arch Psychiatry Clin Neurosci 263:379–384
55. Kaila K, Price TJ, Payne JA et al (2014) Cation-chloride cotransporters in neuronal development, plasticity and disease. Nat Rev Neurosci 15:637–654
56. Kałużna-Czaplińska J, Żurawicz E, Struck W, Markuszewski M (2014) Identification of organic acids as potential biomarkers in the urine of autistic children using gas chromatography/mass spectrometry. J Chromatogr B 966:70–76
57. Kern JK, Geier DA, Adams JB et al (2011) A clinical trial of glutathione supplementation in autism spectrum disorders. Med Sci Monit 17:677–682
58. Kim PM, Aizawa H, Kim PS et al (2005) Serine racemase: activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration. Proc Natl Acad Sci USA 102:2105–2110
59. 1H MR spectroscopy study. Adv Med Sci 57:152–156
60. Kuwabara H, Yamasue H, Koike S et al (2013) Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study. PLoS One 8:73814
61. Labrie V, Lipina T, Roder JC (2008) Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology 200:217–230
62. Lam KSL, Aman MG, Arnold LE (2006) Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 27:254–289
63. Liu Z-Q, Gu X-H, Yang Y-J et al (2016) d-Serine in the nucleus accumbens region modulates behavioral sensitization and extinction of conditioned place preference. Pharmacol Biochem Behav 143:44–56
64. Lozano R, Martinez-Cerdeno V, Hagerman RJ (2015) Advances in the understanding of the Gabaergic neurobiology of FMR1expanded alleles leading to targeted treatments for fragile X spectrum disorder. Curr Pharm Des 21(34):4972–4979
65. MacDermot KD, Bonora E, Sykes N et al (2005) Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. Am J Hum Genet 76:1074–1080
66. Madeira C, Lourenco MV, Vargas-Lopes C et al (2015) d-Serine levels in Alzheimer’s disease: implications for novel biomarker development. Transl Psychiatry 5:561
67. Magistretti PJ, Pellerin L (1999) Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci 354:1155–1163
68. 2+ influx elicited by glutamate: role in neuronal death. Mol Pharmacol 36:106–112
69. −/y mouse model of fragile X syndrome by a novel γ-aminobutyric acid type A receptor-positive allosteric modulator. J Neurosci Res 94:568–578
70. Martina M, Krasteniakov NV, Bergeron R (2003) d-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons. J Physiol 548:411–423
71. McDougle CJ, Naylor ST, Cohen DJ et al (1996) Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 53:993–1000
72. Ming X, Stein TP, Barnes V et al (2012) Metabolic perturbance in autism spectrum disorders: a metabolomics study. J Proteome Res 11:5856–5862
73. Moreno H, Borjas L, Arrieta A et al (1992) Clinical heterogeneity of the autistic syndrome: a study of 60 families. Invest Clin 33:13–31
74. Moreno-Fuenmayor H, Borjas L, Arrieta A et al (1996) Plasma excitatory amino acids in autism. Invest Clin 37:113–128
75. Muller CL, Anacker AMJ, Veenstra-Vanderweele J (2016) The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience 321:24–41
76. Naaijen J, Lythgoe DJ, Amiri H et al (2015) Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies. Neurosci Biobehav Rev 52:74–88
77. 13C HSQC-NMR to improve urinary screening in autism spectrum disorders. Analyst 139:3460–3468
78. Naushad SM, Jain JMN, Prasad CK et al (2013) Autistic children exhibit distinct plasma amino acid profile. Indian J Biochem Biophys 50:474–478
79. Noto A, Fanos V, Barberini L et al (2014) The urinary metabolomics profile of an Italian autistic children population and their unaffected siblings. J Matern Fetal Neonatal Med 27:46–52
80. Nunes EA, MacKenzie EM, Rossolatos D et al (2012) d-Serine and schizophrenia: an update. Expert Rev Neurother 12:801–812
81. Olney JW (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164:719–721
82. Omura Y, Lu D, Jones MK et al (2015) Early detection of autism (ASD) by a non-invasive quick measurement of markedly reduced acetylcholine & DHEA and increased β-Amyloid (1-42), asbestos (chrysotile), titanium dioxide, Al, Hg & often coexisting virus infections (CMV, HPV 16 and 18), bacterial infections etc. in the brain and corresponding safe individualized effective treatment. Acupunct Electrother Res 40:157–187
83. Ongür D, Jensen JE, Prescot AP et al (2008) Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry 64:718–726
84. Ozeki Y, Sekine M, Fujii K et al (2016) Phosphoserine phosphatase activity is elevated and correlates negatively with plasma d-serine concentration in patients with schizophrenia. Psychiatry Res 237:344–350
85. 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry 163:2189–2192
86. Pardo CA, Eberhart CG (2007) The neurobiology of autism. Brain Pathol 17:434–447
87. Parellada M, Penzol MJ, Pina L, Moreno C, Gonzalez-Vioque D, Zalsman G, Arango C (2014) The neurobiology of autism spectrum disorders. Eur Psychiatry 29:11–19
88. Park HR, Lee JM, Moon HE, Lee DS, Kim B-N, Kim J, Kim DG, Paek SH (2016) A short review on the current understanding of autism spectrum disorders. Exp Neurobiol 25(1):1–13
89. Paşca SP, Nemeş B, Vlase L et al (2006) High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. Life Sci 78:2244–2248
90. Paula-Lima AC, Brito-Moreira J, Ferreira ST (2013) Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer’s disease. J Neurochem 126:191–202
91. Perry TL, Hansen S, Christie RG (1978) Amino compounds and organic acids in CSF, plasma, and urine of autistic children. Biol Psychiatry 13:575–586
92. Puig-Alcaraz C, Fuentes-Albero M, Calderón J et al (2015) Increased homocysteine levels correlate with the communication deficit in children with autism spectrum disorder. Psychiatry Res 229:1031–1037
93. Putnam SK, Lopata C, Fox JD et al (2012) Comparison of saliva collection methods in children with high-functioning autism spectrum disorders: acceptability and recovery of cortisol. Child Psychiatry Hum Dev 43:560–573
94. Robertson CE, Ratai E-M, Kanwisher N (2016) Reduced GABAergic action in the autistic brain. Curr Biol 26:80–85
95. Rojas DC (2014) The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. J Neural Transm 121:891–905
96. Rojas DC, Singel D, Steinmetz S et al (2014) Decreased left perisylvian GABA concentration in children with autism and unaffected siblings. Neuroimage 86:28–34
97. Rolf LH, Haarmann FY, Grotemeyer K-H, Kehrer H (1993) Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand 87:312–316
98. Rozas NS, Redell JB, McKenna J III, Moore AN, Gambello MJ, Dash PK (2015) Prolonging the survival of Tsc2 conditional knockout mice by glutamine supplementation. Biochem Biophys Res Commun 457(4):635–639
99. Rubenstein JLR, Merzenich MM (2003) Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2:255–267
100. Rubin DH, Althoff RR, Ehli EA et al (2013) Candidate gene associations with withdrawn behavior. J Child Psychol Psychiatry 54:1337–1345
101. Sacchi S, Binelli G, Pollegioni L (2016) G72 primate-specific gene: a still enigmatic element in psychiatric disorders. Cell Mol Life Sci 73:2029–2039
102. Sacrey L-AR, Bennett JA, Zwaigenbaum L (2015) Early infant development and intervention for autism spectrum disorder. J Child Neurol 30:1921–1929
103. Santini AC, Pierantoni GM, Gerlini R et al (2014) Glix 13, a new drug acting on glutamatergic pathways in children and animal models of autism spectrum disorders. BioMed Res Int 2014:234295
104. Seif T, Simms JA, Lei K et al (2015) d-Serine and d-cycloserine reduce compulsive alcohol intake in rats. Neuropsychopharmacol 40:2357–2367
105. Sheldon AL, Robinson MB (2007) The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int 51:333–355
106. Shimmura C, Suda S, Tsuchiya KJ et al (2011) Alteration of plasma glutamate and glutamine levels in children with high-functioning autism. PLoS One 6:25340
107. Shinohe A, Hashimoto K, Nakamura K et al (2006) Increased serum levels of glutamate in adult patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 30:1472–1477
108. Subramanian M, Timmerman CK, Schwartz JL, Pham DL, Meffert KM (2015) Characterizing autism spectrum disorders by key biochemical pathways. Front Neurosci 9(art. 313):1–18
109. Tirouvanziam R, Obukhanych TV, Laval J et al (2011) Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with autism spectrum disorders. J Autism Dev Disord 42:827–836
110. Tordjman S, Anderson GM, Kermarrec S et al (2014) Altered circadian patterns of salivary cortisol in low-functioning children and adolescents with autism. Psychoneuroendocrinology 50:227–245
111. Tu W-J, Chen H, He J (2012) Application of LC-MS/MS analysis of plasma amino acids profiles in children with autism. J Clin Biochem Nutr 51:248–249
112. Tyzio R, Cossart R, Khalilov I et al (2006) Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery. Science 314:1788–1792
113. Tyzio R, Nardou R, Ferrari DC et al (2014) Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 343:675–679
114. van Elst LT, Maier S, Fangmeier T et al (2014) Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: evidence in support of the excitatory/inhibitory imbalance hypothesis. Mol Psychiatry 19:1314–1325
115. Vizi ES, Kisfali M, Lőrincz T (2013) Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects. Brain Res Bull 93:32–38
116. Wang C, Shimizu-Okabe C, Watanabe K et al (2002) Developmental changes in KCC1, KCC2, and NKCC1 mRNA expressions in the rat brain. Dev Brain Res 139:59–66
117. Woods DL, Kovach CR, Raff H et al (2008) Using saliva to measure endogenous cortisol in nursing home residents with advanced dementia. Res Nurs Health 31:283–294
118. − uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1. J Physiol 557:829–841
119. Yang C-J, Tan H-P, Du Y-J (2014) The developmental disruptions of serotonin signaling may involved in autism during early brain development. Neuroscience 267:1–10
120. Yap IKS, Angley M, Veselkov KA et al (2010) Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res 9:2996–3004
121. Young LJ, Barrett CE (2015) Can oxytocin treat autism? Science 347:825–826
122. Yüksel C, Öngür D (2010) Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol Psychiatry 68:785–794
123. Zhang WQ, Smolik CM, Barba-Escobedo PA et al (2015) Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains. Neuropharmacology 90:1–8
124. Zwaigenbaum L, Bryson SE, Brian J et al (2015) Stability of diagnostic assessment for autism spectrum disorder between 18 and 36 months in a high-risk cohort. Autism Res 9:790–800